Previous 10 | Next 10 |
3 Penny Stocks to Watch as SPRT Stock Climbs Higher Penny stocks are climbing higher again as SPRT stock shows the meteoric potential of former small-caps. For those unfamiliar, Support.com Inc. ( NASDAQ: SPRT ) is a provider of customer support services. And while this alone is a p...
Hoth Therapeutics' mRNA 'Frameshifting' Therapy HT-KIT for Mast Cell Cancers Reduces Size, Spread - Research Published in Molecular Therapy Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm PR Newswire NEW Y...
CohBar (NASDAQ:CWBR) +62% on Q2 earnings Good Times Restaurant (NASDAQ:GTIM) +32% on Q3 earnings Upstart Holdings (NASDAQ:UPST) +22% on Q2 earnings Mogo (NASDAQ:MOGO) +20% on Q2 earnings fuboTV (NYSE:FUBO) +16% on Q2 earnings Lantern Pharma (N...
Hoth Therapeutics (NASDAQ:HOTH) announces that it has initiated a preclinical study of HT-ALZ for the treatment of Alzheimer's disease. The goal of the study is to determine the effects of HT-ALZ on behavioral and pathological markers of Alzheimer's disease and to determine if HT-ALZ can impr...
Hoth Therapeutics Initiates Preclinical Study of HT-ALZ for Alzheimer's Disease PR Newswire NEW YORK , Aug. 2, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company , announced today that it has ...
Hoth Therapeutics ([[HOTH]]) announces positive confirmatory results from in vivo model of HT-003 assets as potential treatment against acne.The model showed that HT-003 reduces the expression of toll-like receptor 2 ((TLR2)), one of the most critical pathways for acne pathophysiology.Th...
Hoth Therapeutics Announces Positive Confirmatory Results from In Vivo Model of HT-003 Assets as Potential Treatment Against Acne PR Newswire NEW YORK , July 13, 2021 /PR Newswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmace...
Hoth Therapeutics (HOTH) announces safety results in cohort 1 of its first in human clinical trial of the proprietary BioLexa platform to treat atopic dermatitis, also known as eczema.Shares up more than 8% premarket.The interim safety review indicates that BioLexa was wel...
Hoth Therapeutics Announces Positive Safety Results from AD001 Cohort 1 of Phase 1b Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis The primary objectives were achieved in cohort one BioLexa was well-tolerated with no treatment related adverse events Ini...
GreenApple78/iStock via Getty Images Hoth Therapeutics ([[HOTH]] -1.2%) has entered into an amendment to a license agreement signed with the U.S. Army Medical Research and Development Command (USAMRDC). Per the original agreement that became effective on December 22, 2020, USAMRDC granted the...
News, Short Squeeze, Breakout and More Instantly...
Hoth Therapeutics Inc. Company Name:
HOTH Stock Symbol:
NASDAQ Market:
Hoth Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment PR Newswire Treatment of pre-clinical subjects showed cognitive benefits that suggest HT-ALZ's mode of action may involve a reduction in brain inflammation, thereby improving cognitiv...